Allarity Therapeutics (ALLR) Goodwill & Intangibles (2020 - 2024)

Allarity Therapeutics (ALLR) has 5 years of Goodwill & Intangibles data on file, last reported at $9.6 million in Q2 2024.

• Quarterly Goodwill & Intangibles fell 1.62% year-over-year to $9.6 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $9.6 million (down 1.62% YoY) and the FY2023 annual result came in at $9.9 million, up 3.37% from the prior year.
• Goodwill & Intangibles eased to $9.6 million in Q2 2024, from $9.7 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $39.0 million in Q3 2021 to a low of $9.5 million in Q3 2023.
• A 5-year average of $15.7 million and a median of $9.9 million in 2023 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2022 — Goodwill & Intangibles tumbled 69.14% — and 2023, when it increased 3.37%.
• Tracing ALLR's Goodwill & Intangibles over 5 years: stood at $30.5 million in 2020, then fell by 7.73% to $28.1 million in 2021, then tumbled by 66.06% to $9.5 million in 2022, then climbed by 3.37% to $9.9 million in 2023, then declined by 3.18% to $9.6 million in 2024.
• The last three Goodwill & Intangibles figures came in at $9.6 million (Q2 2024), $9.7 million (Q1 2024), and $9.9 million (Q4 2023), per Business Quant data.